The global Anti-infective API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-infective API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-infective API.
Report Scope
The Anti-infective API market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-infective API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-infective API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
North China Pharmaceutical
CSPC
Harbin Pharmaceutical Group Pharmaceutical General Factory
Henan Huaxing Pharmaceutical Factory
Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
Zhangjiakou Diha Pharmaceutical
Shandong Lukang Medicine
Zhuhai United Laboratories
Lunan Pharmaceutical Group
Sandoz
Segment by Type
尾-lactam Drugs
Macrolides
Carbapenems
Quinolones
Segment by Application
Antibacterial Drugs for Systemic Use
Antiviral Drugs for Systemic Use
Antigen for Whole Body
Bacteria
Immune Serum and Immunoglobulin
Anti-mycobacterial Drugs
Vaccine
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-infective API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Anti-infective API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Anti-infective API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Anti-infective API Market Overview
1.1 Product Definition
1.2 Anti-infective API Segment by Type
1.2.1 Global Anti-infective API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 尾-lactam Drugs
1.2.3 Macrolides
1.2.4 Carbapenems
1.2.5 Quinolones
1.3 Anti-infective API Segment by Application
1.3.1 Global Anti-infective API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Antibacterial Drugs for Systemic Use
1.3.3 Antiviral Drugs for Systemic Use
1.3.4 Antigen for Whole Body
1.3.5 Bacteria
1.3.6 Immune Serum and Immunoglobulin
1.3.7 Anti-mycobacterial Drugs
1.3.8 Vaccine
1.3.9 Other
1.4 Global Market Growth Prospects
1.4.1 Global Anti-infective API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Anti-infective API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Anti-infective API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Anti-infective API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Anti-infective API Production Market Share by Manufacturers (2019-2024)
2.2 Global Anti-infective API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Anti-infective API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Anti-infective API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Anti-infective API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Anti-infective API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Anti-infective API, Product Offered and Application
2.8 Global Key Manufacturers of Anti-infective API, Date of Enter into This Industry
2.9 Anti-infective API Market Competitive Situation and Trends
2.9.1 Anti-infective API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Anti-infective API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Anti-infective API Production by Region
3.1 Global Anti-infective API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Anti-infective API Production Value by Region (2019-2030)
3.2.1 Global Anti-infective API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Anti-infective API by Region (2025-2030)
3.3 Global Anti-infective API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Anti-infective API Production by Region (2019-2030)
3.4.1 Global Anti-infective API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Anti-infective API by Region (2025-2030)
3.5 Global Anti-infective API Market Price Analysis by Region (2019-2024)
3.6 Global Anti-infective API Production and Value, Year-over-Year Growth
3.6.1 North America Anti-infective API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Anti-infective API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Anti-infective API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Anti-infective API Production Value Estimates and Forecasts (2019-2030)
4 Anti-infective API Consumption by Region
4.1 Global Anti-infective API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Anti-infective API Consumption by Region (2019-2030)
4.2.1 Global Anti-infective API Consumption by Region (2019-2024)
4.2.2 Global Anti-infective API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Anti-infective API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Anti-infective API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Anti-infective API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Anti-infective API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Anti-infective API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Anti-infective API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Anti-infective API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Anti-infective API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Anti-infective API Production by Type (2019-2030)
5.1.1 Global Anti-infective API Production by Type (2019-2024)
5.1.2 Global Anti-infective API Production by Type (2025-2030)
5.1.3 Global Anti-infective API Production Market Share by Type (2019-2030)
5.2 Global Anti-infective API Production Value by Type (2019-2030)
5.2.1 Global Anti-infective API Production Value by Type (2019-2024)
5.2.2 Global Anti-infective API Production Value by Type (2025-2030)
5.2.3 Global Anti-infective API Production Value Market Share by Type (2019-2030)
5.3 Global Anti-infective API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Anti-infective API Production by Application (2019-2030)
6.1.1 Global Anti-infective API Production by Application (2019-2024)
6.1.2 Global Anti-infective API Production by Application (2025-2030)
6.1.3 Global Anti-infective API Production Market Share by Application (2019-2030)
6.2 Global Anti-infective API Production Value by Application (2019-2030)
6.2.1 Global Anti-infective API Production Value by Application (2019-2024)
6.2.2 Global Anti-infective API Production Value by Application (2025-2030)
6.2.3 Global Anti-infective API Production Value Market Share by Application (2019-2030)
6.3 Global Anti-infective API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 North China Pharmaceutical
7.1.1 North China Pharmaceutical Anti-infective API Corporation Information
7.1.2 North China Pharmaceutical Anti-infective API Product Portfolio
7.1.3 North China Pharmaceutical Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 North China Pharmaceutical Main Business and Markets Served
7.1.5 North China Pharmaceutical Recent Developments/Updates
7.2 CSPC
7.2.1 CSPC Anti-infective API Corporation Information
7.2.2 CSPC Anti-infective API Product Portfolio
7.2.3 CSPC Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 CSPC Main Business and Markets Served
7.2.5 CSPC Recent Developments/Updates
7.3 Harbin Pharmaceutical Group Pharmaceutical General Factory
7.3.1 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Corporation Information
7.3.2 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Product Portfolio
7.3.3 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Harbin Pharmaceutical Group Pharmaceutical General Factory Main Business and Markets Served
7.3.5 Harbin Pharmaceutical Group Pharmaceutical General Factory Recent Developments/Updates
7.4 Henan Huaxing Pharmaceutical Factory
7.4.1 Henan Huaxing Pharmaceutical Factory Anti-infective API Corporation Information
7.4.2 Henan Huaxing Pharmaceutical Factory Anti-infective API Product Portfolio
7.4.3 Henan Huaxing Pharmaceutical Factory Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Henan Huaxing Pharmaceutical Factory Main Business and Markets Served
7.4.5 Henan Huaxing Pharmaceutical Factory Recent Developments/Updates
7.5 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
7.5.1 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Corporation Information
7.5.2 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Product Portfolio
7.5.3 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Main Business and Markets Served
7.5.5 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Recent Developments/Updates
7.6 Zhangjiakou Diha Pharmaceutical
7.6.1 Zhangjiakou Diha Pharmaceutical Anti-infective API Corporation Information
7.6.2 Zhangjiakou Diha Pharmaceutical Anti-infective API Product Portfolio
7.6.3 Zhangjiakou Diha Pharmaceutical Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Zhangjiakou Diha Pharmaceutical Main Business and Markets Served
7.6.5 Zhangjiakou Diha Pharmaceutical Recent Developments/Updates
7.7 Shandong Lukang Medicine
7.7.1 Shandong Lukang Medicine Anti-infective API Corporation Information
7.7.2 Shandong Lukang Medicine Anti-infective API Product Portfolio
7.7.3 Shandong Lukang Medicine Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Shandong Lukang Medicine Main Business and Markets Served
7.7.5 Shandong Lukang Medicine Recent Developments/Updates
7.8 Zhuhai United Laboratories
7.8.1 Zhuhai United Laboratories Anti-infective API Corporation Information
7.8.2 Zhuhai United Laboratories Anti-infective API Product Portfolio
7.8.3 Zhuhai United Laboratories Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Zhuhai United Laboratories Main Business and Markets Served
7.7.5 Zhuhai United Laboratories Recent Developments/Updates
7.9 Lunan Pharmaceutical Group
7.9.1 Lunan Pharmaceutical Group Anti-infective API Corporation Information
7.9.2 Lunan Pharmaceutical Group Anti-infective API Product Portfolio
7.9.3 Lunan Pharmaceutical Group Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Lunan Pharmaceutical Group Main Business and Markets Served
7.9.5 Lunan Pharmaceutical Group Recent Developments/Updates
7.10 Sandoz
7.10.1 Sandoz Anti-infective API Corporation Information
7.10.2 Sandoz Anti-infective API Product Portfolio
7.10.3 Sandoz Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Sandoz Main Business and Markets Served
7.10.5 Sandoz Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Anti-infective API Industry Chain Analysis
8.2 Anti-infective API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Anti-infective API Production Mode & Process
8.4 Anti-infective API Sales and Marketing
8.4.1 Anti-infective API Sales Channels
8.4.2 Anti-infective API Distributors
8.5 Anti-infective API Customers
9 Anti-infective API Market Dynamics
9.1 Anti-infective API Industry Trends
9.2 Anti-infective API Market Drivers
9.3 Anti-infective API Market Challenges
9.4 Anti-infective API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
North China Pharmaceutical
CSPC
Harbin Pharmaceutical Group Pharmaceutical General Factory
Henan Huaxing Pharmaceutical Factory
Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
Zhangjiakou Diha Pharmaceutical
Shandong Lukang Medicine
Zhuhai United Laboratories
Lunan Pharmaceutical Group
Sandoz
听
听
*If Applicable.
